About: Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury. Argenica Therapeutics Limited was incorporated in 2019 and is based in Nedlands, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.12 (+9.52%)
AGN ASX Argenica Therapeutics Ltd
Argenica Therapeutics Ltd share price
Atividade de preço de AGN
Último preço
$ 0,120
Variação (24h)
0,01 AUD (9,52%)
Volume
173.13K
Volume (média 4 sem.)
-
Abertura
$ 0,11
Variação do dia
$ 0,11 - $ 0,12
Fechamento anterior
$ 0,11
Último negócio
30 Oct, 1:24 am GMT+0
Atrasado
30 Oct, 1:24 am GMT+0
AGN price performance
Atrasado
30 Oct, 1:24 am GMT+0
quote.marketSignals